AVDL

AVDL

USD

Avadel Pharmaceuticals plc Ordinary Share

$18.780+0.030 (0.160%)

Цена в режиме реального времени

Healthcare
Drug Manufacturers - Specialty & Generic
Ирландия

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$18.750

Максимум

$18.780

Минимум

$18.680

Объем

1.08M

Фундаментальные показатели компании

Рыночная капитализация

1.8B

Отрасль

Drug Manufacturers - Specialty & Generic

Страна

Ireland

Статистические данные торговли

Средний объем

2.43M

Биржа

NGM

Валюта

USD

52-недельный диапазон

Минимум $6.38Текущая $18.780Максимум $19.06

Связанные новости

Analyst Upgrades

UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20

UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals from Buy to Neutral and maintains the price target from $20 to $20.

Просмотреть больше
UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20
Analyst Upgrades

Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target

Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals from Outperform to Market Perform and announces $18.5 price target.

Просмотреть больше
Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target
PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

Просмотреть больше
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
PR Newswire

HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Просмотреть больше
HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM
Analyst Upgrades

Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20

Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals from Buy to Hold and lowers the price target from $22 to $20.

Просмотреть больше
Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20
Analyst Upgrades

Needham Downgrades Avadel Pharmaceuticals to Hold

Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals from Buy to Hold.

GlobeNewswire

Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement

DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.